<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since the discovery of leptin in 1994, we now have a better understanding of the cellular and molecular mechanisms underlying its biological effects </plain></SENT>
<SENT sid="1" pm="."><plain>In addition to its established anti-<z:hpo ids='HP_0001513'>obesity</z:hpo> effects, leptin exerts <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> actions that are independent of its regulation of body weight and food intake </plain></SENT>
<SENT sid="2" pm="."><plain>In particular, leptin can correct <z:mp ids='MP_0002055'>diabetes</z:mp> in animal models of type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, long-term leptin replacement therapy improves glycaemic control, insulin sensitivity and plasma <z:chebi fb="4" ids="17855">triglycerides</z:chebi> in patients with severe <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> due to <z:hpo ids='HP_0009125'>lipodystrophy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>These results have spurred enthusiasm for the use of leptin therapy to treat <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we review the current understanding of the glucoregulatory functions of leptin, emphasizing its central mechanisms of action and lessons learned from clinical studies, and discuss possible therapeutic applications of leptin in the treatment of type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>